{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "JPY", "firstTradeDateMilliseconds": 1632441600000, "priceHint": 2, "epsTrailingTwelveMonths": -23.48, "sharesOutstanding": 12711700, "bookValue": 155.29, "fiftyDayAverage": 466.18, "fiftyDayAverageChange": 34.820007, "fiftyDayAverageChangePercent": 0.0746922, "twoHundredDayAverage": 378.86, "twoHundredDayAverageChange": 122.140015, "twoHundredDayAverageChangePercent": 0.32238826, "marketCap": 6478381056, "priceToBook": 3.226222, "sourceInterval": 15, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "regularMarketChangePercent": 7.9741383, "regularMarketPrice": 501.0, "marketState": "CLOSED", "exchange": "JPX", "shortName": "RENASCIENCE INC", "longName": "Renascience Inc.", "messageBoardId": "finmb_558183586", "exchangeTimezoneName": "Asia/Tokyo", "exchangeTimezoneShortName": "JST", "gmtOffSetMilliseconds": 32400000, "market": "jp_market", "esgPopulated": false, "regularMarketChange": 37.0, "regularMarketTime": 1683872102, "regularMarketDayHigh": 504.0, "regularMarketDayRange": "475.0 - 504.0", "regularMarketDayLow": 475.0, "regularMarketVolume": 364500, "regularMarketPreviousClose": 464.0, "bid": 499.0, "ask": 502.0, "fullExchangeName": "Tokyo", "financialCurrency": "JPY", "regularMarketOpen": 480.0, "averageDailyVolume3Month": 172553, "averageDailyVolume10Day": 154140, "fiftyTwoWeekLowChange": 219.0, "fiftyTwoWeekLowChangePercent": 0.7765958, "fiftyTwoWeekRange": "282.0 - 540.0", "fiftyTwoWeekHighChange": -39.0, "fiftyTwoWeekHighChangePercent": -0.072222225, "fiftyTwoWeekLow": 282.0, "fiftyTwoWeekHigh": 540.0, "earningsTimestamp": 1683784800, "earningsTimestampStart": 1683784800, "earningsTimestampEnd": 1683784800, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "symbol": "4889.T"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "2-3-6", "address2": "Nihonbashihoncho Chuo-ku", "city": "Tokyo", "zip": "103-0023", "country": "Japan", "phone": "81 3 6262 0873", "website": "https://www.renascience.co.jp", "industry": "Medical Devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "longBusinessSummary": "Renascience Inc. engages in the development and commercialization of pharmaceuticals and medical devices. The company is developing RS5614, a PAI-1 inhibitor product candidate for use in the treatment of chronic myeloid leukemia, malignant melanoma, non-small cell lung cancer, novel coronavirus infections, and FGF23-related hypophosphatemic rickets; and RS8001, a water-soluble vitamin for use in the treatment of premenstrual syndrome/premenstrual dysphoric mood disorder, autism spectrum disorder, and menopausal disorder. It is also developing RS9001, a disposable ultrafine endoscope; artificial intelligence based medical solutions; and diagnostic solutions. The company was incorporated in 2000 and is headquartered in Chuo, Japan.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Dr. Koji  Naito Ph.D.", "title": "Pres, CEO & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}